Your browser doesn't support javascript.
loading
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19.
Sciascia, Savino; Aprà, Franco; Baffa, Alessandra; Baldovino, Simone; Boaro, Daniela; Boero, Roberto; Bonora, Stefano; Calcagno, Andrea; Cecchi, Irene; Cinnirella, Giacoma; Converso, Marcella; Cozzi, Martina; Crosasso, Paola; De Iaco, Fabio; Di Perri, Giovanni; Eandi, Mario; Fenoglio, Roberta; Giusti, Massimo; Imperiale, Daniele; Imperiale, Gianlorenzo; Livigni, Sergio; Manno, Emilpaolo; Massara, Carlo; Milone, Valeria; Natale, Giuseppe; Navarra, Mauro; Oddone, Valentina; Osella, Sara; Piccioni, Pavilio; Radin, Massimo; Roccatello, Dario; Rossi, Daniela.
Afiliación
  • Sciascia S; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy.
  • Aprà F; ASL Città di Torino, Italy.
  • Baffa A; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy.
  • Baldovino S; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy.
  • Boaro D; ASL Città di Torino, Italy.
  • Boero R; ASL Città di Torino, Italy.
  • Bonora S; ASL Città di Torino, Italy.
  • Calcagno A; ASL Città di Torino, Italy.
  • Cecchi I; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy.
  • Cinnirella G; ASL Città di Torino, Italy.
  • Converso M; ASL Città di Torino, Italy.
  • Cozzi M; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy.
  • Crosasso P; ASL Città di Torino, Italy.
  • De Iaco F; ASL Città di Torino, Italy.
  • Di Perri G; ASL Città di Torino, Italy.
  • Eandi M; ASL Città di Torino, Italy.
  • Fenoglio R; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy.
  • Giusti M; ASL Città di Torino, Italy.
  • Imperiale D; ASL Città di Torino, Italy.
  • Imperiale G; ASL Città di Torino, Italy.
  • Livigni S; ASL Città di Torino, Italy.
  • Manno E; ASL Città di Torino, Italy.
  • Massara C; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy.
  • Milone V; ASL Città di Torino, Italy.
  • Natale G; ASL Città di Torino, Italy.
  • Navarra M; ASL Città di Torino, Italy.
  • Oddone V; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy.
  • Osella S; ASL Città di Torino, Italy.
  • Piccioni P; ASL Città di Torino, Italy.
  • Radin M; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy.
  • Roccatello D; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy. dario.roccatello@unito.it.
  • Rossi D; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy.
Clin Exp Rheumatol ; 38(3): 529-532, 2020.
Article en En | MEDLINE | ID: mdl-32359035
Asunto(s)
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Bases de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Anticuerpos Monoclonales Humanizados / Betacoronavirus Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Rheumatol Año: 2020 Tipo del documento: Article País de afiliación: Italia
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Bases de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Anticuerpos Monoclonales Humanizados / Betacoronavirus Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Rheumatol Año: 2020 Tipo del documento: Article País de afiliación: Italia